External assessment of the EUROMACS right-sided heart failure risk score

Abstract The EUROMACS Right-Sided Heart Failure Risk Score was developed to predict right ventricular failure (RVF) after left assist device (LVAD) placement. predictive ability of the score has not been tested in other cohorts. We performed a single center analysis continuous-flow (CF) LVAD cohort (n = 254) where we calculated risk scores and assessed for heart implantation. Thirty-nine percent patients (100/254) had post-operative RVF, which 9% (23/254) required prolonged inotropic support 5% (12/254) RVAD For who RVF implantation, there 45% increase hazards death on (HR 1.45, 95% CI 0.98–2.2, p 0.066). Two variables (Hemoglobin Right Atrial Pressure Pulmonary Capillary Wedge ratio) were our cohort. Overall, poor external discrimination with area under curve 58% (95% 52–66%). Further work is necessary enhance